Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelJean‐Cosme Dodart, Steven M. Paul, Xin Wu et al.|Nature Neuroscience|2002Cited by 858
A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide VaccineHui Jing Yu, Jean‐Cosme Dodart|Movement Disorders|2022Cited by 51
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapyJacqui Nimmo, James A. R. Nicoll, Ajay Verma et al.|Alzheimer s Research & Therapy|2020Cited by 48
Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical TrialsJacqui Nimmo, Jean‐Cosme Dodart, Louise Kelly et al.|Frontiers in Neuroscience|2021Cited by 40
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Jean‐Cosme Dodart, Yu Sun et al.|Nature Medicine|2024Cited by 38